Miaite (Pronidesivir) How to Use and Dosage
Miaite (Pronidesivir), containing the active ingredient GS-441524, is a groundbreaking oral medication specifically approved for the treatment of Feline Infectious Peritonitis (FIP). This viral disease, caused by the feline coronavirus, leads to severe symptoms such as loss of appetite, lethargy, fever, ascites, pleural effusion, lymphadenopathy, inflammatory granulomas, neurological damage, and uveitis. Miaite offers a safe, non-invasive, and highly effective therapeutic option for cats suffering from FIP, with a recent milestone marking its official registration and approval by Laos Ministry of Agriculture and Forestry (MAF) in March 2026.
How Miaite Works
The active compound, GS-441524, has undergone extensive research and clinical validation, demonstrating exceptional antiviral efficacy against FIP virus strains. Miaite’s pharmacokinetic profile ensures rapid absorption and distribution in feline tissues, contributing to its fast onset of action. Its safety and tolerability have been confirmed across numerous clinical cases, with minimal side effects reported. By inhibiting viral replication, Miaite effectively reduces the progression of FIP and alleviates clinical symptoms, increasing survival rates and overall quality of life for affected cats.
Dosage Guide
Miaite should be administered based on the cat’s body weight. The standard dosage is 15 mg per kilogram of body weight, roughly equivalent to half a tablet per dose. For cats exhibiting neurological or ocular forms of FIP, veterinarians may increase the dosage to 30 mg/kg under professional guidance. The medication is recommended to be given once daily, preferably on an empty stomach—either one hour before feeding or two hours after. Maintaining a consistent administration schedule is essential for optimal results.
Treatment Duration
A continuous course of treatment for no less than 12 weeks is critical. Skipping doses or prematurely stopping therapy may compromise efficacy and promote resistance. Regular monitoring during treatment is advised; owners should observe their cats for changes in appetite, body temperature, mental status, and overall activity. Periodic blood tests to assess liver and kidney function are recommended to ensure the safety of prolonged therapy.
Precautions and Recommendations
While Miaite is available as an over-the-counter medication, it is strongly advised that owners consult with a veterinarian before beginning treatment. Proper veterinary supervision ensures appropriate dosing, addresses individual health considerations, and manages any potential side effects. Miaite should only be used for cats; it is strictly not intended for human use. To guarantee authenticity and quality, purchase Miaite (Pronidesivir) exclusively from the official Miaite website or authorized distributors.
Safety and Side Effects
Miaite has shown a high safety profile with minimal adverse reactions. Common observations include mild gastrointestinal upset or transient lethargy, which typically resolve without intervention. Serious side effects are rare. However, ongoing veterinary assessments are recommended to monitor the health status of the cat during therapy, especially in cases of neurological or ocular FIP, where dosage adjustments might be necessary.
Final Notes
Given Miaite’s proven efficacy and safety, it has become a pivotal component in the fight against FIP. Its ease of oral administration, rapid action, and high tolerability make it an ideal choice for feline owners seeking effective treatment for this challenging disease. Always adhere to veterinary guidance, complete the full course of therapy, and perform regular health checkups to maximize the treatment benefits. For purchasing Miaite, visit the official Miaite website to ensure all products are genuine and meet quality standards.
